A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center found that implanting collagen tiles during brain surgery to deliver targeted radiation therapy improved tumor control, lowered the risk of recurrence and improved overall survival compared with the current standard of care for patients with newly diagnosed brain metastases who need surgery.